Ahead of World Cancer Research Day, an oncologist explained why cancers that look alike can respond differently to the same ...
Surveyed NCCN centers universally reported active shortages, and more than one-fifth faced simultaneous shortages of at least ...
The FDA granted final approval to OMCAZIO, a new cabozantinib capsule formulation for certain patients with kidney, liver and ...
Your friend doesn’t need you to become an expert in cancer. Most of the time, what they really want is to feel normal again.
Lu-177 vipivotide tetraxetan shifted from post-taxane mCRPC to pre-chemotherapy mCRPC and then metastatic hormone-sensitive ...
Pleural-based masses on baseline CT led to biopsy, PET-based primary-site determination, and stage IV ovarian cancer ...
Trials are designed with patient safety in mind while helping researchers determine whether a new treatment is safe and effective. Some cancer trials do use a placebo, an inactive pill, but patients ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hyrnuo (sevabertinib) for adults with locally ...
Ostomy appliances are patient-specific prescriptions, requiring customized wafer cutting, pouch capacity, and adhesive compatibility; “one size fits all” substitution risks leakage and skin breakdown.
Therapy planning shifted from intended autologous transplant to CAR-T; detailed counseling helped align expectations and ...
FDA approves BESREMi for adults with essential thrombocythemia, offering a new treatment option for people living with this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results